CVS HEALTH Corp Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CVS HEALTH Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • CVS HEALTH Corp Operating Income (Loss) for the quarter ending September 30, 2024 was $832M, a 77.5% decline year-over-year.
  • CVS HEALTH Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was $9.52B, a 32.1% decline year-over-year.
  • CVS HEALTH Corp annual Operating Income (Loss) for 2023 was $13.7B, a 72.8% increase from 2022.
  • CVS HEALTH Corp annual Operating Income (Loss) for 2022 was $7.95B, a 40.2% decline from 2021.
  • CVS HEALTH Corp annual Operating Income (Loss) for 2021 was $13.3B, a 4.32% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.52B $832M -$2.86B -77.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $12.4B $3.05B -$189M -5.84% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $12.6B $2.27B -$1.18B -34.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $13.7B $3.37B -$286M -7.82% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 $14B $3.69B +$7.61B Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $6.42B $3.23B -$1.44B -30.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $7.86B $3.45B -$99M -2.79% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $7.95B $3.66B +$1.31B +56% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 $6.64B -$3.92B -$6.98B -228% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $13.6B $4.67B +$343M +7.93% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $13.3B $3.55B -$32M -0.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $13.3B $2.35B -$178M -7.05% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-07
Q3 2021 $13.5B $3.06B -$188M -5.79% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $13.7B $4.33B -$354M -7.56% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $14B $3.58B +$119M +3.44% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $13.9B $2.52B -$513M -16.9% Oct 1, 2020 Dec 31, 2020 8-K 2023-05-25
Q3 2020 $14.4B $3.25B +$321M +11% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $14.1B $4.68B +$1.35B +40.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $12.8B $3.46B +$768M +28.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $12B $3.04B +$2.21B +269% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-18
Q3 2019 $9.77B $2.93B +$354M +13.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $9.42B $3.33B +$4.71B Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $4.72B $2.69B +$694M +34.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $4.02B $824M -$2.29B -73.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 $6.31B $2.57B +$70M +2.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-18
Q2 2018 $6.24B -$1.37B -$3.49B -165% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-18
Q1 2018 $9.74B $2B +$197M +11% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-18
Q4 2017 $9.54B $3.11B +$114M +3.8% Oct 1, 2017 Dec 31, 2017 8-K 2019-08-08
Q3 2017 $9.42B $2.5B -$320M -11.3% Jul 1, 2017 Sep 30, 2017 8-K 2019-08-08
Q2 2017 $9.74B $2.12B -$236M -10% Apr 1, 2017 Jun 30, 2017 8-K 2019-08-08
Q1 2017 $9.98B $1.8B -$386M -17.7% Jan 1, 2017 Mar 31, 2017 8-K 2019-08-08
Q4 2016 $10.4B $3B +$271M +9.93% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-14
Q3 2016 $10.1B $2.82B +$493M +21.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-14
Q2 2016 $9.6B $2.36B +$95M +4.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-14
Q1 2016 $9.51B $2.19B +$53M +2.49% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-14
Q4 2015 $9.45B $2.73B +$408M +17.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-09
Q3 2015 $9.05B $2.33B +$85M +3.79% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-09
Q2 2015 $8.96B $2.26B +$54M +2.45% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-09
Q1 2015 $8.91B $2.13B +$108M +5.34% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-09
Q4 2014 $8.8B $2.32B +$104M +4.69% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-09
Q3 2014 $8.7B $2.25B +$92M +4.27% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-09
Q2 2014 $8.6B $2.21B +$236M +12% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-09
Q1 2014 $8.37B $2.02B +$330M +19.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-09
Q4 2013 $8.04B $2.22B -$82M -3.57% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-10
Q3 2013 $8.12B $2.15B +$342M +18.9% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-10
Q2 2013 $7.78B $1.97B +$270M +15.9% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-10
Q1 2013 $7.51B $1.69B +$297M +21.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-10
Q4 2012 $7.21B $2.3B +$342M +17.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-11
Q3 2012 $6.87B $1.81B +$228M +14.4% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-11
Q2 2012 $6.64B $1.7B +$218M +14.7% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-11
Q1 2012 $6.42B $1.4B +$92M +7.05% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-11
Q4 2011 $6.33B $1.96B +$196M +11.1% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-15
Q3 2011 $6.13B $1.58B +$106M +7.17% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-15
Q2 2011 $6.03B $1.48B -$10M -0.67% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-15
Q1 2011 $6.04B $1.31B -$99M -7.05% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-15
Q4 2010 $6.14B $1.76B Oct 1, 2010 Dec 31, 2010 10-K 2012-02-17
Q3 2010 $1.48B Jul 1, 2010 Sep 30, 2010 10-K 2012-02-17
Q2 2010 $1.49B Apr 1, 2010 Jun 30, 2010 10-K 2012-02-17
Q1 2010 $1.4B Jan 1, 2010 Mar 31, 2010 10-K 2012-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.